| 185 |
decreased |
gene expression
(GO:0010467)
|
3-hydroxyacyl-CoA dehydrogenase type-2
(PR:000008774)
|
140: Decreased, HSD17B10 expression
|
| 184 |
increased |
|
fatty acid
(CHEBI:35366)
|
327: Accumulation, Fatty acid
|
| 183 |
decreased |
peroxisome proliferator activated receptor signaling pathway
(GO:0035357)
|
peroxisome proliferator-activated receptor gamma
(PR:000013058)
|
2 Events
|
| 182 |
decreased |
peroxisome proliferator activated receptor signaling pathway
(GO:0035357)
|
peroxisome proliferator-activated receptor delta
(PR:000013057)
|
232: Decreased, PPAR-beta activation
|
| 181 |
decreased |
peroxisome proliferator activated receptor signaling pathway
(GO:0035357)
|
peroxisome proliferator-activated receptor alpha
(PR:000013056)
|
3 Events
|
| 180 |
abnormal |
|
plasma membrane
(GO:0005886)
|
169: Disruption, Membrane integrity
|
| 179 |
increased |
|
membrane
(GO:0016020)
|
46: Accumulation, Biological membranes
|
| 178 |
occurrence |
|
fatty liver
(MESH:D005234)
|
345: N/A, Liver Steatosis
|
| 177 |
functional change |
mitochondrion disassembly
(GO:0061726)
|
mitochondrion
(GO:0005739)
|
None
|
| 176 |
increased |
|
triglyceride
(CHEBI:17855)
|
291: Accumulation, Triglyceride
|
| 175 |
increased |
fatty acid biosynthetic process
(GO:0006633)
|
fatty acid
(CHEBI:35366)
|
2 Events
|
| 174 |
increased |
gene expression
(GO:0010467)
|
acyl-CoA desaturase
(PR:000014497)
|
2 Events
|
| 173 |
increased |
fatty acid synthase activity
(GO:0004312)
|
fatty acid synthase
(PR:000007348)
|
116: Activation, FAS
|
| 172 |
increased |
SREBP signaling pathway
(GO:0032933)
|
sterol regulatory element-binding protein 1
(PR:000015611)
|
3 Events
|
| 171 |
increased |
signaling
(GO:0023052)
|
carbohydrate-responsive element-binding protein
(PR:000010460)
|
66: Activation, ChREBP
|
| 170 |
increased |
positive regulation of fatty acid transport
(GO:2000193)
|
fatty acid
(CHEBI:35366)
|
115: Increase, Fatty acid influx
|
| 169 |
increased |
gene expression
(GO:0010467)
|
platelet glycoprotein 4
(PR:000001905)
|
54: Up Regulation, CD36
|
| 168 |
increased |
peroxisome proliferator activated receptor signaling pathway
(GO:0035357)
|
peroxisome proliferator-activated receptor gamma
(PR:000013058)
|
228: peroxisome proliferator activated receptor promoter demethylation
|
| 167 |
increased |
signaling
(GO:0023052)
|
oxysterols receptor LXR-alpha
(PR:000011395)
|
2 Events
|
| 166 |
increased |
signaling
(GO:0023052)
|
oxysterols receptor LXR-beta
(PR:000011394)
|
167: Activation, LXR
|
| 165 |
increased |
kidney failure
(MP:0003606)
|
|
759: Increased, Kidney Failure
|
| 164 |
increased |
signaling
(GO:0023052)
|
5-hydroxytryptamine receptor 2C
(PR:000001168)
|
9: Activation, 5HT2c
|
| 163 |
increased |
|
hepatocellular carcinoma
(MESH:D006528)
|
3 Events
|
| 162 |
increased |
hepatocyte proliferation
(GO:0072574)
|
|
269: Induction, Sustained Cell Proliferation
|
| 161 |
increased |
hepatotoxicity
(MI:2141)
|
|
270: Induction, Sustained Hepatotoxicity
|